BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36625991)

  • 1. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn's disease.
    Zhou G; Liu H; Wei P; He Q; Zhang J; Shi Q; Liu T; Liu S
    Amino Acids; 2023 Mar; 55(3):349-358. PubMed ID: 36625991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease.
    Liu H; Xu M; He Q; Wei P; Ke M; Liu S
    Front Med (Lausanne); 2022; 9():814839. PubMed ID: 36160171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
    Jagt JZ; Struys EA; Ayada I; Bakkali A; Jansen EEW; Claesen J; van Limbergen JE; Benninga MA; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2022 May; 28(5):755-763. PubMed ID: 34757415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative colitis or Crohn's disease? Pitfalls and problems.
    Feakins RM
    Histopathology; 2014 Feb; 64(3):317-35. PubMed ID: 24266813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.
    Starr AE; Deeke SA; Ning Z; Chiang CK; Zhang X; Mottawea W; Singleton R; Benchimol EI; Wen M; Mack DR; Stintzi A; Figeys D
    Gut; 2017 Sep; 66(9):1573-1583. PubMed ID: 27216938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
    Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
    World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.
    Ma R; Zhu Y; Li X; Hu S; Zheng D; Xiong S; Xu S; Xiang L; Zhao M; Tang C; Zeng Z; Chen M; Feng R
    Inflamm Bowel Dis; 2023 Oct; 29(10):1524-1535. PubMed ID: 37195904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
    Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
    World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Fabian O; Hradsky O; Drskova T; Mikus F; Zamecnik J; Bronsky J
    Dig Dis Sci; 2018 Jul; 63(7):1811-1818. PubMed ID: 29541900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.